Browsing Tag
European Medicines Agency CHMP
2 posts
Cadrenal Therapeutics shares surge as FDA alignment clears a key hurdle for CAD-1005 Phase 3 strategy
Cadrenal Therapeutics gains FDA alignment on a CAD-1005 Phase 3 trial as CVKD shares surge. See why financing and efficacy remain critical.
Eli Lilly ($LLY) surges past $1.07tn as EU oncology win and Medicare GLP-1 program align with analyst upgrade
Eli Lilly NYSE LLY surges 6.3 percent to record $1,208.12 on EU Jaypirca approval, Medicare GLP-1 Bridge Program and Leerink price target raise. Read more.